IMAC Holdings’ The Back Space Announces the Completion of Two Additional Retail Spinal Care Locations
October 26 2021 - 8:30AM
IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”) today
announces the completion of two additional locations of “The Back
Space” retail healthcare centers specializing in chiropractic and
spinal care services within Walmart stores. The Back Space will
open two locations in the Nashville area this week to complement
the original store opening in Murfreesboro, Tennessee.
“We are excited to continue our progress in
opening additional ‘The Back Space’ locations. We have established
a platform to deliver affordable spinal health and wellness
services in a superior location,” commented Jeffrey Ervin, Chief
Executive Officer of IMAC. “As we execute the ten-store pilot, we
have identified several opportunities to improve on subsequent
store openings which will reduce completion time and opening costs.
Our well-established buildout process drives strong value and will
be a benefit beyond the pilot program should we expand our store
count.”
IMAC’s The Back Space offers walk-in and
appointment-based spinal health and wellness services priced at $25
per treatment, with memberships available for $65 per month that
are valid at any The Back Space location. More information can be
found at www.back.co.
About IMAC Holdings, Inc.
IMAC Holdings owns and manages health and
wellness centers that deliver sports medicine, orthopedic, and life
science therapies for movement restricting diseases. IMAC is
comprised of three business segments: outpatient medical centers,
The Back Space, and a clinical research division. With treatments
to address the aging population, IMAC Holdings owns or manages more
than 15 outpatient medical clinics and has partnered with several
active and former professional athletes, including Ozzie Smith,
David Price, Mike Ditka, and Tony Delk to promote a minimally
invasive approach to sports medicine. IMAC’s The Back Space retail
spine health and wellness treatment centers deliver chiropractic
care within Walmart locations. IMAC’s research division is
currently conducting a Phase I clinical trial evaluating a
mesenchymal stem cell therapy candidate for bradykinesia due to
Parkinson’s disease. For more information visit
www.imacholdings.com.
# # #
Safe Harbor Statement
This press release contains forward-looking
statements. These forward-looking statements, and terms such as
“anticipate,” “expect,” “believe,” “may,” “will,” “should” or other
comparable terms, are based largely on IMAC's expectations and are
subject to a number of risks and uncertainties, certain of which
are beyond IMAC's control. Actual results could differ materially
from these forward-looking statements as a result of, among other
factors, risks and uncertainties associated with its ability to
raise additional funding, its ability to maintain and grow its
business, variability of operating results, its ability to maintain
and enhance its brand, its development and introduction of new
products and services, the successful integration of acquired
companies, technologies and assets, marketing and other business
development initiatives, competition in the industry, general
government regulation, economic conditions, dependence on key
personnel, the ability to attract, hire and retain personnel who
possess the skills and experience necessary to meet customers’
requirements, and its ability to protect its intellectual property.
IMAC encourages you to review other factors that may affect its
future results in its registration statement and in its other
filings with the Securities and Exchange Commission. In light of
these risks and uncertainties, there can be no assurance that the
forward-looking information contained in this press release will in
fact occur.
IMAC Press Contact: Laura
Fristoelfristoe@imacrc.com
Investor Relations: Bret Shapiro(516)
222-2560brets@coreir.com
IMAC (NASDAQ:IMAC)
Historical Stock Chart
From Apr 2024 to May 2024
IMAC (NASDAQ:IMAC)
Historical Stock Chart
From May 2023 to May 2024